DERM Projected Dividend Yield
Journey Medical Corp ( NASDAQ : DERM )Journey Medical Corporation is a commercial-stage pharmaceutical company. Co. is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes seven branded and two authorized generic prescription drugs for dermatological conditions that are marketed in the U.S.. Its marketed products, which have been approved by the U.S. Food and Drug Administration (FDA) for sale, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox and Luxamend. It sells two authorized generic products, including sulconazole nitrate cream and solution and doxycycline hyclate immediate release 50mg tablets. 20 YEAR PERFORMANCE RESULTS |
DERM Dividend History Detail DERM Dividend News DERM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |